NovoCure Limited (NVCR) Debt by Year
NovoCure Limited carried $195.0M in long-term debt against $93.5M in cash and equivalents at the end of fiscal year 2025. This represents an increase of 100.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters NovoCure Limited has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NVCR Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-Q | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $195.0M+100.5% | $97.3M-82.9% | $568.8M+0.6% | $565.5M+0.6% | $562.2M+30.8% | $429.9M+187.7% | $149.4M+0.1% | $149.3M+53.3% | $97.3M+1.2% | $96.2M+316.6% | $23.1M | $0 | N/A |
| Cash & Equivalents | $93.5M-42.9% | $163.8M-32.0% | $240.8M+108.8% | $115.3M-44.8% | $208.8M-11.0% | $234.7M+32.3% | $177.3M+26.1% | $140.6M+78.9% | $78.6M-21.2% | $99.8M-16.4% | $119.4M+107.3% | $57.6M-67.2% | $175.9M |
NVCR Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | $195.0M+100.5% | N/A | N/A | N/A | $97.3M-82.9% | N/A | N/A | $569.7M+0.6% | $568.8M+0.6% | $568.0M+0.6% |
| Cash & Equivalents | $93.7M-37.4% | $87.5M-31.2% | $93.5M-42.9% | $342.1M+84.5% | $149.6M-9.2% | $127.3M-72.0% | $163.8M-32.0% | $185.4M+19.7% | $164.8M+5.0% | $453.8M+144.0% | $240.8M+108.8% | $154.9M-36.5% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More NovoCure Limited financials
Frequently Asked Questions
What was NovoCure Limited's long-term debt in fiscal year 2025?
NovoCure Limited carried $195.0M in long-term debt against $93.5M in cash and equivalents at the end of fiscal year 2025.
How fast is NovoCure Limited's long-term debt growing?
NovoCure Limited (NVCR) long-term debt rose by 100.5% year over year, from $97.3M to $195.0M in fiscal year 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what NovoCure Limited (NVCR) reported on that line in every period on record.